More on PALI

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/12/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Palisade Bio Inc. (NQ:PALI)
Delayed: 1.63 -0.01 (0.61%)
Prev. Close $1.64  
Open$1.64 
52 Wk High$ 
52 Wk Low$ 
Day High$1.67 
Day Low$1.61 
P/E N/A  
EPS$ 
Volume2,546,088 

Friends, Peers and Foes (?): AKTX, AMIX, CNSP, GRI, MBRX (more...)

Mar 2, 2026 09:00 AM Palisade Bio Announces Participation in Two Upcoming Investor Conferences
Feb 24, 2026 04:07 PM Stifel Starts Palisade Bio Inc. (PALI) at Buy
Feb 23, 2026 08:40 AM Palisade Bio presents PALI-2108 data showing clinical response in UC patients
Feb 23, 2026 08:40 AM Palisade Bio Reports Rapid Clinical, Histologic and New Mechanistic Colon Tissue RNA Sequencing Data Supporting Targeted Activity of PALI-2108 at ECCO 2026
Feb 17, 2026 04:41 PM Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 17, 2026 04:29 PM Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:00 PM Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: PERCEPTIVE ADVISORS LLC
Feb 17, 2026 12:09 PM Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: Squadron Capital Management LLC
Feb 17, 2026 08:45 AM Palisade Bio adds IBD expert to clinical advisory board
Feb 17, 2026 08:45 AM Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board
View All Articles

Entities mentioned with PALI

View All Entities